Cardiovascular Effects of a New Positive Inotropic Agent, (−)-(R)-1-(p-Hydroxyphenyl)-2-[(3,4-Dimethoxyphenethyl) Amino]-Ethanol (TA-064) in the Anesthetized Dog and Isolated Guinea Pig Heart
Open Access
- 31 December 1983
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 35 (4), 415-423
- https://doi.org/10.1254/jjp.35.415
Abstract
The positive inotropic effect of TA-064, (-) - (R) -1- (p-hydroxyphenyl) -2- [(3, 4-dimethoxyphenethyl) amino] ethanol, was studied in the anesthetized dog and isolated guinea pig heart. An intravenous administration of TA-064 dose-dependently increased the cardiac contractile force with little effect on blood pressure in dogs. The positive inotropic activity of TA-064 was 1/100 that of isoproterenol and similar to that of dobutamine. This effect of TA-064 was stereospecific, and it was blocked by practolol. Thus TA-064 has beta1 -adrenoceptor agonistic action. The positive inotropic effect of TA-064 was more pronounced than the positive chronotropic effect, compared with those of isoproterenol. Similar effect of TA-064 was observed in the reserpinized dog and in the isolated perfused heart of the guinea pig as well. TA-064 administered intraduodenally at a dose of 0.1 mg/kg increased contractile force by 120% of the control, and the effect lasted for more than 160 min. TA-064 given in the femoral artery demonstrated a very weak vasodilating effect on the artery. TA-064 is an orally active, positive inotropic agent. The selective positive inotropic action of TA-064 may result from its beta1 -adrenoceptor agonistic property.This publication has 24 references indexed in Scilit:
- Human cardiac beta-adrenergic receptors: Subtype heterogeneity delineated by direct radioligand bindingLife Sciences, 1983
- Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased heartsThe American Journal of Cardiology, 1983
- Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043Journal of Cardiovascular Pharmacology, 1982
- beta-Adrenergic Receptor Subtypes: Properties, Distribution, and RegulationAnnual Review of Neuroscience, 1981
- Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.Circulation, 1981
- Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptorsAmerican Heart Journal, 1978
- Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heartLife Sciences, 1972
- A comparison of the β-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenalineJournal of Pharmacy and Pharmacology, 1970
- Differentiation of receptors responsive to isoproterenolLife Sciences, 1967
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967